Cost-effectiveness of De-Escalated Molecular Subtype Dependent Use of Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer in a Swedish Setting
Frontiers in oncology（2025）
Key words
cost-effectiveness analysis,muscle invasive bladder cancer,molecular subtype,neoadjuvant chemotherapy,radical cystectomy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined